| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 10/04/2001 | WO2001072994A2 Human urothelial cell specific uroplakin transcriptional regulatory sequences, vectors comprising the same, and methods of use thereof |
| 10/04/2001 | WO2001072990A1 A new polypeptide- human atp- dependent serine protease 12 and the polynucleotide encoding it |
| 10/04/2001 | WO2001072983A1 A new polypeptide- human peroxydase 11 and the polynucleotide encoding it |
| 10/04/2001 | WO2001072973A2 Regulation of human heparanase-like enzyme |
| 10/04/2001 | WO2001072846A2 Ligands directed to the non-secretory component, non-stalk region of pigr and methods of use thereof |
| 10/04/2001 | WO2001072843A2 Regulation of human c-myb-related genes |
| 10/04/2001 | WO2001072837A2 Methods of modulating drug clearance mechanisms by altering sxr activity |
| 10/04/2001 | WO2001072835A1 Family of human sodium cation channels and use thereof |
| 10/04/2001 | WO2001072833A2 Human ephrin-like receptor |
| 10/04/2001 | WO2001072825A2 Apoptin-associating protein |
| 10/04/2001 | WO2001072824A2 Apoptin-associating protein |
| 10/04/2001 | WO2001072822A2 Genes involved in intestinal inflammatory diseases and use thereof |
| 10/04/2001 | WO2001072781A2 Human genes and expression products |
| 10/04/2001 | WO2001072780A2 Polynucleotides for diagnosing mammary gland cancer |
| 10/04/2001 | WO2001072773A2 Genes isolated from dendritic cells, gene products and methods employing the same |
| 10/04/2001 | WO2001072771A2 Insulin and igf-1 receptor agonists and antagonists |
| 10/04/2001 | WO2001072765A1 ALTERATION OF CELLULAR BEHAVIOR BY ANTISENSE MODULATION OF mRNA PROCESSING |
| 10/04/2001 | WO2001072341A2 Methods of treating neoplasia with combinations of target cell-specific adenovirus, chemotherapy and radiation |
| 10/04/2001 | WO2001072340A1 Aids virus vaccine with the use of sendai virus vector |
| 10/04/2001 | WO2001072339A2 Method of treatment of conditions involving obstruction of blood flow |
| 10/04/2001 | WO2001072295A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 10/04/2001 | WO2001072294A2 Method of treating hepatitis delta viral infection |
| 10/04/2001 | WO2001072283A1 Cationic liposomes |
| 10/04/2001 | WO2001072280A2 Microspheres for gene therapy |
| 10/04/2001 | WO2001072277A2 Immunotherapeutic methods and compositions |
| 10/04/2001 | WO2001072264A2 Pro-liposomal encapsulated preparations (iv) |
| 10/04/2001 | WO2001072119A2 Non-human animal model for growth deficiency and information processing or cognitive function defects and use thereof |
| 10/04/2001 | WO2001044198A8 Amphiphilic quinolylpolyamines as transfer agents for biologically active macromolecules |
| 10/04/2001 | WO2001036638A8 Polypeptides and nucleic acids encoding same |
| 10/04/2001 | WO2001036602A3 Pak5 a member of the p21-activated kinase (pak) protein family, nucleic acids and methods related to the same |
| 10/04/2001 | WO2001036456A3 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 10/04/2001 | WO2001032685A3 Gene expression directed by a super-psa promoter |
| 10/04/2001 | WO2001032070A3 Reagents and methods for diagnosing, imaging and treating atherosclerotic disease |
| 10/04/2001 | WO2001027256A9 Chimeric transcriptional regulatory element and methods for prostate-targeted gene expression |
| 10/04/2001 | WO2001021773A3 Human endothelin converting enzyme-like proteins and polynucleotides encoding the same |
| 10/04/2001 | WO2001018208A3 Interferon induced polynucleotides and proteins encoded thereby |
| 10/04/2001 | WO2001008701A3 Invasive bacteria based viral vaccines |
| 10/04/2001 | WO2001004135A3 Crosslinked dna condensate compositions and gene delivery methods |
| 10/04/2001 | WO2000071564A8 Isolated nucleic acids of the p-hyde family, p-hyde proteins, and methods of inducing susceptibility to induction of cell death in cancer |
| 10/04/2001 | WO2000046377A9 Genetically engineered retroviral vector particles capable of infecting non-dividing cells |
| 10/04/2001 | WO2000043515A3 Methods of monitoring hiv drug resistance |
| 10/04/2001 | WO2000039279A9 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
| 10/04/2001 | US20010027251 Mimic or modulate activity of wild-type nucleic acids thereby affecting protein production or activity |
| 10/04/2001 | US20010027184 Serine/threonine protein kinase (H-SGK2) |
| 10/04/2001 | US20010027183 Polypeptides and polynucleotides of the thymidylate kinase family (tdk); screening for antibiotics |
| 10/04/2001 | US20010027182 Spinocerebellar ataxia type 1 (SCA1); using chaperone proteins to aid in recognition/hydrolysis of mutant ataxin-1 by the proteasome; treating Alzheimer's, Parkinson's, prion disorders, dentatorubral-pallidoluysian atrophy and SCA1 |
| 10/04/2001 | US20010026938 Containing DNA expressing the adenovirus protease; for gene transfer purposes, vaccines |
| 10/04/2001 | US20010026799 Genome with mutation expresses native immediate early gene from genome with delayed kinetics; gene therapy |
| 10/04/2001 | US20010026794 Two heterologous DNA encoding gene products; prolonged half-life |
| 10/04/2001 | EP1138774A2 Defective recombinant adenoviruses expressing cytokines for use in antitumoral treatement |
| 10/04/2001 | EP1138773A2 Use of plasmids for the manufacture of a composition for vaccine treatment by human and animal |
| 10/04/2001 | EP1138768A2 Apoptin-associating protein AAP-5 |
| 10/04/2001 | EP1138765A1 Apoptin-associating proteins AAP-5 and AAP-6 |
| 10/04/2001 | EP1138694A1 Hirulog-like peptide |
| 10/04/2001 | EP1138693A1 Novel g protein-coupled receptor protein and dna thereof |
| 10/04/2001 | EP1138313A1 Proliposomes |
| 10/04/2001 | EP1137796A2 Micromonospora echinospora genes encoding for biosynthesis of calicheamicin and self-resistance thereto |
| 10/04/2001 | EP1137793A2 Novel nucleic acid transferring agents, compositions containing them and uses |
| 10/04/2001 | EP1137792A1 A recombinant vector expressing multiple costimulatory molecules and uses thereof |
| 10/04/2001 | EP1137785A1 STREPTOCOCCAL C5a PEPTIDASE VACCINE |
| 10/04/2001 | EP1137780A1 Therapeutic and diagnostic uses of protein tyrosine phosphatase tc-ptp |
| 10/04/2001 | EP1137775A1 htfIIIA HUMAN GENE AND CODED hTFIIIA PROTEIN |
| 10/04/2001 | EP1137773A2 Growth factor homolog zvegf3 |
| 10/04/2001 | EP1137771A2 Methods for preventing cardiac hypertrophy and heart failure by inhibition of mef2 transcription factor |
| 10/04/2001 | EP1137764A1 New medical use of gene and vector encoding a multisubstrate deoxyribonucleosidase |
| 10/04/2001 | EP1137758A2 Method and composition for preserving viruses |
| 10/04/2001 | EP1137664A2 Protein transduction system and methods of use thereof |
| 10/04/2001 | EP1137658A1 METHODS OF MODULATING TUMOR NECROSIS FACTOR $g(a)-INDUCED EXPRESSION OF CELL ADHESION MOLECULES |
| 10/04/2001 | EP1137656A1 31 human secreted proteins |
| 10/04/2001 | EP0835309B1 Vaccine for infectious agents, composition for treating and preventing hiv infections |
| 10/04/2001 | EP0784693B1 Viral vectors for gene therapy |
| 10/04/2001 | EP0639979B1 LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF |
| 10/04/2001 | DE10048710A1 Composition for treating or preventing tumors, comprises plasmids, and optionally recombinant viruses, that express mucin and carcino-embryonal antigen |
| 10/04/2001 | CA2407045A1 Apoptin-associating protein |
| 10/04/2001 | CA2405502A1 Method of treating hepatitis delta viral infection |
| 10/04/2001 | CA2404780A1 Targeted chromosomal genomic alterations with modified single stranded oligonucleotides |
| 10/04/2001 | CA2404756A1 Ligands directed to the non-secretory component, non-stalk region of pigr and methods of use thereof |
| 10/04/2001 | CA2404660A1 Materials and methods relating to a novel splice variant of a na+ dependent glutamate transporter |
| 10/04/2001 | CA2404495A1 Human tap-like protein (transporter associated in antigen processing/presentation) |
| 10/04/2001 | CA2404448A1 Genes involved in intestinal inflammatory diseases and use thereof |
| 10/04/2001 | CA2404432A1 Compositions and methods for identifying and targeting cancer cells |
| 10/04/2001 | CA2404428A1 High specificity marker detection |
| 10/04/2001 | CA2404233A1 Compositions and methods for the therapy and diagnosis of lung cancer |
| 10/04/2001 | CA2404085A1 Human urothelial cell specific uroplakin transcriptional regulatory sequences, vectors comprising uroplakin-specific transcriptional regulatory sequences, and methods of use thereof |
| 10/04/2001 | CA2404060A1 Methods of treating neoplasia with combinations of target cell-specific adenovirus, chemotherapy and radiation |
| 10/04/2001 | CA2403909A1 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 10/04/2001 | CA2403857A1 Anti-angiogenic and anti-tumor properties of matin and other laminin domains |
| 10/04/2001 | CA2403800A1 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 10/04/2001 | CA2403515A1 Anti-angiogenic and anti-tumor properties of vascostatin and other nidogen domains |
| 10/04/2001 | CA2402780A1 Insulin and igf-1 receptor agonists and antagonists |
| 10/04/2001 | CA2402613A1 Cationic liposomes |
| 10/04/2001 | CA2402439A1 Methods of modulating drug clearance mechanisms by altering sxr activity |
| 10/04/2001 | CA2400573A1 Alteration of cellular behavior by antisense modulation of mrna processing |
| 10/03/2001 | CN1315866A Method of modulating memory effector T-cells using CD2-binding agent, and compositions |
| 10/03/2001 | CN1315572A Polypeptide-human ATP-dependent serine protein hydrolase 12 and polynucleotide for coding it |
| 10/03/2001 | CN1315532A Polypeptide-human peroxidase 11 and polynucleotide for coding it |
| 10/03/2001 | CN1315207A Heterogenous skin transfected by recombined genes |
| 10/02/2001 | US6297371 Cytolysing raw cells, applying to anion exchanger which begins desorbing dna and rna at different ionic strengths, then eluting nucleic acids and/or oligonucleotides; treating preparation at first or last step to remove endotoxin |
| 10/02/2001 | US6297366 Nucleotide sequences coding tumor suppressor protein; for use as a diagnostic tool in the detection and treatment of cancer |
| 10/02/2001 | US6297359 Polypeptide for use in the treatment of diabetes, dietetics, hypertension and premature atherosclerosis |